Scholars Central

Conference abstractPublished 14 May 2018

Functional Tricuspid Regurgitation in Rheumatic Heart Disease: Results of De Vega annuloplasty

Authors: Zouizra, F. Aboutaleb, R.El Houati, D.Boumzebra, S. El Karimi, D.Benzarwal, M. El Hattaoui

Cadi Ayyad University, Morocco

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objectives: Tricuspid regurgitation (TR) in patients with rheumatic heart disease is associated with poor outcome and predicts poor survival, heart failure, and reduced functional capacity. We review our experience in DeVega annuloplasty for functional TR. Methods: Between 2007 and 2015: 520 patients (mean age, 37 years) underwent a De Vega tricuspide annuloplasty with concomitant rheumatic mitral and or aortic valve disease operated. All patients were investigated perioperatively by Doppler echocardiography. Echocardiographic assessment of tricuspid incompetence was on the basis of gradation of tricuspid regurgitation severity according to color Doppler flow criteria, the flow convergence region proximal to the regurgitant orifice (PISA), the size of the tricuspid annulus, and estimation of the pulmonary artery systolic pressure by continuous Doppler. Median tricuspid insufficiency was 3+. All patients underwent De Vega tricuspid annuloplasty at the time of mitral and or aortic surgery. Results: There were 23 postoperative deaths. Four patients (who had a severe pulmonary hypertension and or right ventricular dysfunction) had developed a right cardiac failure 1 to 2 weeks after surgery. The postoperative course was uneventful in all other patients. The mean follow was 5.5 years. Post-operative echo study: There was 1+ or less TR in 453 patients (87%), moderate TR 2+ in 37 patients (7%) and severe TR 3+ in 7 (1.34%) patients who had a severe pulmonary hypertension. Conclusions: DeVega tricuspid annuloplasty is a simple, short, and inexpensive procedure with few complications. In a developing country like Morocco, De Vega annuloplasty remains the procedure of choice in the management of functional tricuspid valve incompetence.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Zouizra”
  • BylineArticles whose byline prints “F. Aboutaleb”
  • BylineArticles whose byline prints “R.El Houati”
  • BylineArticles whose byline prints “D.Boumzebra”
  • BylineArticles whose byline prints “S. El Karimi”
  • BylineArticles whose byline prints “D.Benzarwal”
  • BylineArticles whose byline prints “M. El Hattaoui”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels